PATENT CLAIM ANALYSIS

Application Number: 15990495
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["514", "006200"]

Abstract:
An insulin analog with an improved in vitro effect compared with native insulin, a nucleic acid encoding the same, an expression vector including the nucleic acid, a transformant introduced with the expression vector, a method of producing the insulin analog from the transformant, a pharmaceutical composition for treating diabetes containing the insulin analog as an active ingredient, and a method for treating diabetes using the insulin analog or the pharmaceutical composition.

Claim (Index 9):
The method of  claim 8 , wherein the transformant is  E. coli.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 1.95
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15250459', '15113027', '15513748', '15846485', '13130976']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8235251973331905
- 35 USC 102 Novelty (BERT): 0.574559000149184
- Combined Prediction Score: 0.7986285776147899
- Mean Citation Score: 452.294464
- Max Citation Score: 639.04944
- Similarity Product: 347.52132996774674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test